JPT Peptide Technologies
JPT Peptide Technologies is a leading provider and quality leader for innovative peptide-based services and products in all development phases of immunotherapies. Our proprietary technologies cover cost effective antigen and neo-epitope discovery and qualification, cellular and humoral immune response monitoring and various therapeutic applications. All production and services are regulated according to ISO 9001:2015 guidelines. Our long track record of successful collaborations and >1000 peer-reviewed papers make us more than a vendor for your immunotherapy development.